secwatch / observer
8-K filed March 19, 2026, 7:59 PM ET ticker MOVE CIK 0001734750
M&A confidence high sentiment neutral materiality 0.90

Movano completes reverse merger with Corvex, resolves Nasdaq deficiency, appoints new CEO

Corvex, Inc.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001213900-26-031846
form_type
8-K
ticker
MOVE
cik
0001734750
company_name
Corvex, Inc.
filed_at
2026-03-19T23:59:59+00:00
discovered_at
2026-05-14T18:02:36.030752+00:00
generated_at
2026-05-15T09:39:10.141482+00:00
sec_items
["1.01", "5.03", "3.01", "3.02", "3.03", "5.02", "7.01", "9.01"]
event_type
m_and_a
sentiment
neutral
materiality_score
0.9
calibrated_materiality_score
0.9
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001213900-26-031846
json_url
https://secwatch.observer/filing/0001213900-26-031846.json
markdown_url
https://secwatch.observer/filing/0001213900-26-031846.md
text_url
https://secwatch.observer/filing/0001213900-26-031846.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1734750/000121390026031846/0001213900-26-031846-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1734750/000121390026031846/ea0282032-8k_movano.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Source-grounded claims

e4639bf5d93ff5c5b519b67324e7627808d4b341

Corvex, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

October 1, 2025, the Company received a written notice (the “Notice”) from the Listing Qualifications Department of Nasdaq Stock Market (“Nasdaq”) indicating that it was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing (the “Stockholders’ Equity Requirement”) and served as an additional basis of delisting before the Nasdaq Hearings Panel (the “Panel”). In its Quarterly Report on Form 10-Q for the fiscal year ended June 30, 2025, filed with the U.S

SEC 8-K Item 3.01 confidence 0.95 SEC evidence

4f953da8ddbffbdbb9e7f440c81d3bf5d6115216

Corvex, Inc.: Movano filed Certificates of Designations for Series B, C, and D Preferred Stock with the Delaware Secretary of State, amending its Certificate of Incorporation (effective 2026-03-19).

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. Series B Convertible Preferred Stock On March 19, 2026, Movano filed a Certificate of Designations of the Series B Preferred Stock with the Secretary of State of the State of Delaware (the “Series B Certificate of Designations”) in connection with the Merger referenced in Item 1.01 above.

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

Comparable filings

Enviri II Corp

New Enviri completes spin-off; starts trading June 2 under NVRI; ~$1.2B revenue, ~$140M EBITDA

Enviri II Corp June 1, 2026, 5:18 PM ET m_and_a Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 7.01, 9.01

same fact type: governance_change same SEC item: 1.01, 3.03, 5.02, 5.03, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. Series B Convertible Preferred Stock On March 19, 2026, Movano filed a Certificate of Designations of the Series B Preferred Stock with the Secretary of State of the State of Delaware (the “Series B Certificate of Designations”) in connection with the Merger referenced in Item 1.01 above.

Comparable filing

In connection with the Spin-Off, the Board adopted the Code of Conduct, a copy of which is available on New Enviri’s website at www.enviri.com.

Filing page SEC filing

APAD

Enhanced Group completes de-SPAC merger with Enhanced Ltd; redemptions of $201.7M

Enhanced Group Inc. May 8, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 5.06, 3.02, 9.01, 4.01, 3.01, 3.03, 5.01, 5.02, 5.03, 5.05, 7.01

same fact type: governance_change same SEC item: 1.01, 3.01, 3.02, 3.03, 5.02, 5.03, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. Series B Convertible Preferred Stock On March 19, 2026, Movano filed a Certificate of Designations of the Series B Preferred Stock with the Secretary of State of the State of Delaware (the “Series B Certificate of Designations”) in connection with the Merger referenced in Item 1.01 above.

Comparable filing

As a result of the Business Combination, the Company ceased being a shell company

Filing page SEC filing

CPRX

Angelini Pharma to acquire Catalyst Pharma for $4.1B ($31.50/share), premium 28% to VWAP

CATALYST PHARMACEUTICALS, INC. May 7, 2026, 7:59 PM ET m_and_a Items 1.01, 5.03, 7.01, 8.01, 9.01

same fact type: governance_change same SEC item: 1.01, 5.03, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. Series B Convertible Preferred Stock On March 19, 2026, Movano filed a Certificate of Designations of the Series B Preferred Stock with the Secretary of State of the State of Delaware (the “Series B Certificate of Designations”) in connection with the Merger referenced in Item 1.01 above.

Comparable filing

On May 6, 2026, the Board of Directors approved and adopted an amendment (the “ Forum Selection Amendment ”) to the Company’s existing By-Laws that amends Article VIII, Section 8.1 of the By-Laws of the Company.

Filing page SEC filing

DVN

Devon completes all-stock merger with Coterra; combined company retains DVN ticker

DEVON ENERGY CORP/DE May 7, 2026, 7:59 PM ET m_and_a Items 2.01, 5.02, 5.03, 7.01, 9.01

same fact type: governance_change same SEC item: 5.02, 5.03, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. Series B Convertible Preferred Stock On March 19, 2026, Movano filed a Certificate of Designations of the Series B Preferred Stock with the Secretary of State of the State of Delaware (the “Series B Certificate of Designations”) in connection with the Merger referenced in Item 1.01 above.

Comparable filing

On May 7, 2026, the Company filed an amendment to the Company’s restated certificate of incorporation (the “ Authorized Share Charter Amendment ”), effective as of such date, increasing the number of authorized shares of Company Common Stock from 1,000,000,000 to 2,000,000,000.

Filing page SEC filing

SUJA

Suja Life completes IPO of 8.9M shares at $21/share; closes May 8, 2026

SUJA LIFE, INC. May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 3.03, 5.03, 5.02, 9.01

same fact type: governance_change same SEC item: 1.01, 3.02, 3.03, 5.02, 5.03, 9.01 similar materiality

This filing

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. Series B Convertible Preferred Stock On March 19, 2026, Movano filed a Certificate of Designations of the Series B Preferred Stock with the Secretary of State of the State of Delaware (the “Series B Certificate of Designations”) in connection with the Merger referenced in Item 1.01 above.

Comparable filing

On May 7, 2026, the Company filed an amended and restated certificate of incorporation (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware

Filing page SEC filing

SONM

DNA X receives Nasdaq delisting notice; issues $3.05M convertible note to insider

DNA X, Inc. May 27, 2026, 4:35 PM ET regulatory Items 1.01, 2.03, 3.01, 3.02, 9.01

same fact type: exchange_compliance_notice same SEC item: 1.01, 3.01, 3.02, 9.01 similar materiality

This filing

October 1, 2025, the Company received a written notice (the “Notice”) from the Listing Qualifications Department of Nasdaq Stock Market (“Nasdaq”) indicating that it was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing (the “Stockholders’ Equity Requirement”) and served as an additional basis of delisting before the Nasdaq Hearings Panel (the “Panel”). In its Quarterly Report on Form 10-Q for the fiscal year ended June 30, 2025, filed with the U.S

Comparable filing

May 22, 2026, the Company received a delisting determination letter from the Staff advising the Company that unless the Company requests a hearing before a Nasdaq Hearing Panel (the “Panel”) to appeal Nasdaq’s delisting

Filing page SEC filing

XHLD

TEN Holdings receives Nasdaq equity deficiency notice; issues 500k shares for $500k

TEN Holdings, Inc. May 26, 2026, 4:05 PM ET regulatory Items 1.01, 3.01, 3.02, 9.01

same fact type: exchange_compliance_notice same SEC item: 1.01, 3.01, 3.02, 9.01 similar materiality

This filing

October 1, 2025, the Company received a written notice (the “Notice”) from the Listing Qualifications Department of Nasdaq Stock Market (“Nasdaq”) indicating that it was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing (the “Stockholders’ Equity Requirement”) and served as an additional basis of delisting before the Nasdaq Hearings Panel (the “Panel”). In its Quarterly Report on Form 10-Q for the fiscal year ended June 30, 2025, filed with the U.S

Comparable filing

May 26, 2026, the Company received a deficiency letter from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that it is not in compliance with Nasda

Filing page SEC filing

AGAE

AGAE receives Nasdaq delisting notice over bid price <$1.00 and late 10-K; will appeal

Allied Gaming & Entertainment Inc. May 11, 2026, 5:09 PM ET regulatory Items 3.01, 5.03, 7.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 3.01, 5.03, 7.01, 9.01 similar materiality

This filing

October 1, 2025, the Company received a written notice (the “Notice”) from the Listing Qualifications Department of Nasdaq Stock Market (“Nasdaq”) indicating that it was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing (the “Stockholders’ Equity Requirement”) and served as an additional basis of delisting before the Nasdaq Hearings Panel (the “Panel”). In its Quarterly Report on Form 10-Q for the fiscal year ended June 30, 2025, filed with the U.S

Comparable filing

termination before an independent Hearings Panel (the “Panel”) by May 13, 2026. On November 4, 2025, Staff notified the Company that the bid price of the Common Stock had closed at less than $1.00 per share over 30 consecutive business days, and, as a result, did not comply with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”). The Staff Determination was issued pursuant to Nasdaq Listing Rule 5810(c)(3)(A) on the grounds that the Company has not regained compliance with the Minimum Bid Price Rule during a 180-day compliance period and is not eligible for a second 180-day complian

Filing page SEC filing

Source: SEC EDGAR
accession 0001213900-26-031846

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.